Fragile X Syndrome

Defining the biology of autism

When approaching faculty to gauge interest in a new Feinberg center focusing on autism, Peter Penzes, Ph.D., Ruth and Evelyn Dunbar Professor of Psychiatry and Behavioral Sciences, received puzzled responses from some professors ...

Apr 09, 2018
popularity19 comments 2

New genetic clues found in fragile X syndrome

Scientists have gained new insight into fragile X syndrome—the most common cause of inherited intellectual disability—by studying the case of a person without the disorder, but with two of its classic symptoms.

Jan 16, 2015
popularity139 comments 0

Fragile X syndrome (FXS), Martin–Bell syndrome, or Escalante's syndrome (more commonly used in South American countries), is a genetic syndrome that is the most common known single-gene cause of autism and the most common inherited cause of intellectual disability. It results in a spectrum of intellectual disability ranging from mild to severe as well as physical characteristics such as an elongated face, large or protruding ears, and larger testes (macroorchidism), behavioral characteristics such as stereotypic movements (e.g. hand-flapping), and social anxiety.

Fragile X syndrome is associated with the expansion of the CGG trinucleotide repeat affecting the fragile X mental retardation 1 (FMR1) gene on the X chromosome, resulting in a failure to express the fragile X mental retardation protein (FMRP), which is required for normal neural development. Depending on the length of the CGG repeat, an allele may be classified as normal (unaffected by the syndrome), a premutation (at risk of fragile X associated disorders), or full mutation (usually affected by the syndrome). A definitive diagnosis of fragile X syndrome is made through genetic testing to determine the number of CGG repeats. Testing for premutation carriers can also be carried out to allow for genetic counselling.

There is currently no drug treatment that has shown benefit specifically for fragile X syndrome. However, medications are commonly used to treat symptoms of attention deficit and hyperactivity, anxiety, and aggression. Supportive management is important in optimising functioning in individuals with fragile X syndrome, and may involve speech therapy, occupational therapy, and individualised educational and behavioural programs.

J. Purdon Martin and Julia Bell in 1943, described a pedigree of X-linked mental disability, without considering the macroorchidism (larger testicles). In 1969 Herbert Lubs first sighted an unusual "marker X chromosome" in association with mental disability. In 1970 Frederick Hecht coined the term "fragile site".

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

What learning looks like in the brain

When we learn the connections between neurons strengthen. Addiction or other neurological diseases are linked to abnormally strong connections. But what does learning look like on the cellular and molecular level? How do ...

Multiple sclerosis may be linked to sheep disease toxin

Exposure to a toxin primarily found in sheep could be linked to the development of multiple sclerosis (MS) in humans, new research suggests.Carried out by the University of Exeter and MS Sciences Ltd., the study has found ...

Eating fish could prevent Parkinson's disease

A new study from Chalmers University of Technology, Sweden, shines more light on the link between consumption of fish and better long-term neurological health. Parvalbumin, a protein found in great quantities in several fish ...

Fat cells seem to remember unhealthy diet

It only takes 24 hours for a so-called precursor fat cell to reprogram its epigenetic recipe for developing into a fat cell. This change occurs when the cell is put into contact with the fatty acid palmitate or the hormone ...